02:57 EDT 26th August 2019 | BioPortfolio

Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world.

Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, oncology and thrombosis. Lantus® is the main insulin product in the global market, with annual sales exceeding $4.8m. Other major prescription drugs produced by Sanofi-Aventis are Lovenox®, Taxotere®, Plavix®, Aprovel®, Eloxatin®, and Multaq®.

Sanofi Pasteur is the vaccine division of this company, and is helping lead this area of health care, with the production of Polio, Pertussis, influenza and travel vaccines. There is also a veterinary group within Sanofi-Aventis.

Source; and

Add the Sanofi-Aventis News Channel to your RSS reader;

Follow the Sanofi-Aventis Twitter feed;

Quick Search

review and buy Sanofi-Aventis market research data and corporate reports here